This article was taken from Pharmafile Summer 2022, page 22. Samedan Ltd
Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery
This Might Also Be of Interest

Orally Inhaled Drug products; Bioequivalence Models
Publications, Pharmaceutical, Drug Delivery Innovations, Brand Differentiation, Market Insights, Product Solutions

Navigating the Development for Orally Inhaled and Nasal Drug Products
Publications, Pharmaceutical, Market Insights, Product Solutions, Drug Delivery Innovations

Navigating pMDI Reformulation 2.0
Publications, Pharmaceutical, Sustainability, Drug Delivery Innovations, Market Insights, Product Solutions

Developing More Sustainable pMDIs: A Q&A on Motivation, Progress and Challenges
Publications, Pharmaceutical, Sustainability, Brand Differentiation, Market Insights, Product Solutions